ArticleTranslational lung cancer research2024

EGFR inhibitors plus dabrafenib and trametinib in patients with EGFR-mutant lung cancer and resistance mediated by BRAF

Wenyue Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.